Promacta (Eltrombopag) Copay Assistance
Novartis and various foundations
This program offers financial assistance for Promacta (eltrombopag) medication, aiming to significantly reduce patients' out-of-pocket costs. QuickRx helps commercially insured patients enroll in manufacturer copay card programs and assists Medicare, Medicaid, and uninsured patients in accessing foundation grants and patient assistance programs. The goal is to eliminate financial barriers to treatment for conditions like ITP, aplastic anemia, or hepatitis C.
- Covers
- financial assistance
- Enrollment cycle
- rolling
Apply
Application goes directly to Novartis and various foundations. RxCopays does not receive compensation.
Go to application →Status source
Apply for Promacta (Eltrombopag) Copay Assistance Now
Rare-disease support beyond financial help
This grant covers 2 rare conditions. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: